Filling the need for trusted information on national health issues
The Hill: COVID-19 vaccines must go to rich and poor countries, warns advocate “The world will not return to normal until a vaccine against the coronavirus is distributed widely and not just to developed nations, one of the leading vaccine experts said in a wide-ranging interview Wednesday. Seth Berkley, who…
Financial Times: U.K. strikes deal for 60m Covid-19 vaccine doses with Sanofi and GSK “The U.K. has agreed to buy up to 60m doses of a vaccine being developed by Sanofi and GlaxoSmithKline if the companies are able to prove its efficacy against Covid-19 in clinical trials to start in…
NPR: 2 Coronavirus Vaccines Move To Final Testing Phase “Two companies announced [Monday] that they are beginning widespread testing of potential coronavirus vaccines. One comes from a collaboration between the National Institutes of Health and the U.S. biotech company Moderna. The other is from a collaboration between the pharmaceutical giant…
White House: President Trump Is Leading a Once-in-a-Generation Effort to Ensure Americans Have Access to a COVID-19 Vaccine This fact sheet discusses U.S. efforts to “ensure safe vaccines, therapeutics, and diagnostics are developed, manufactured, and distributed in unprecedented time and scale in response to COVID-19” (7/27).
Devex: Q&A: Tackling the global NCD burden (7/27). Devex: Q&A: Taking on NGO leadership in the COVID crisis (Cornish, 7/27). Devex: How to empower health workers: Lessons learned from ‘On the Frontlines’ (Donback, 7/24). Global Press Journal: Cervical Cancer Claims Lives as Hospital Backlog Grows in Zambia (Phiri, 7/26). Global…
POLITICO: Trump administration invests $472M more in Moderna vaccine candidate “The Trump administration is going to pump another $472 million into expanding Moderna’s clinical trial to test the safety and efficacy of its coronavirus vaccine candidate…” (Roubein, 7/26). Reuters: Moderna gets further $472 million U.S. award for coronavirus vaccine development…
The Hill: U.S. negotiates 100 million doses of coronavirus vaccine from Pfizer that will be free to Americans “Pfizer and BioNTech, a German biotech company, announced Wednesday that the U.S. has reached a $1.95 billion deal with them for an initial order of 100 million doses of their coronavirus vaccine.…
New York Times: Some Vaccine Makers Say They Plan to Profit From Coronavirus Vaccine “Executives from four companies in the race to produce a coronavirus vaccine — AstraZeneca, Johnson & Johnson, Moderna Therapeutics, and Pfizer — told lawmakers on Tuesday that they are optimistic their products could be ready by…
HHS: U.S. Government Engages Pfizer to Produce Millions of Doses of COVID-19 Vaccine “The U.S. Department of Health and Human Services and the Department of Defense (DoD) today announced an agreement with U.S.-based Pfizer Inc. for large-scale production and nationwide delivery of 100 million doses of a COVID-19 vaccine in…
New York Times: Three Coronavirus Vaccine Developers Report Promising Initial Results “The race for a vaccine against the coronavirus intensified on Monday as three competing laboratories released promising results from early trials in humans. Now comes the hard part: proving that any of the vaccines protects against the virus, and…